FDMT
Price
$5.98
Change
-$0.34 (-5.38%)
Updated
Dec 18, 04:59 PM (EDT)
102 days until earnings call
HMTXF
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Dec 17 closing price
Ad is loading...

FDMT vs HMTXF

Header iconFDMT vs HMTXF Comparison
Open Charts FDMT vs HMTXFBanner chart's image
4D Molecular Therapeutics
Price$5.98
Change-$0.34 (-5.38%)
Volume$29.1K
CapitalizationN/A
Hemostemix
Price$0.05
Change-$0.00 (-0.00%)
Volume$10.08K
CapitalizationN/A
FDMT vs HMTXF Comparison Chart
Loading...
FDMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HMTXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FDMT vs. HMTXF commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FDMT is a Hold and HMTXF is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (FDMT: $5.97 vs. HMTXF: $0.05)
Brand notoriety: FDMT and HMTXF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FDMT: 180% vs. HMTXF: 59%
Market capitalization -- FDMT: $292.16M vs. HMTXF: $9.34M
FDMT [@Biotechnology] is valued at $292.16M. HMTXF’s [@Biotechnology] market capitalization is $9.34M. The market cap for tickers in the [@Biotechnology] industry ranges from $482.1B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FDMT’s FA Score shows that 0 FA rating(s) are green whileHMTXF’s FA Score has 1 green FA rating(s).

  • FDMT’s FA Score: 0 green, 5 red.
  • HMTXF’s FA Score: 1 green, 4 red.
According to our system of comparison, HMTXF is a better buy in the long-term than FDMT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FDMT’s TA Score shows that 2 TA indicator(s) are bullish while HMTXF’s TA Score has 3 bullish TA indicator(s).

  • FDMT’s TA Score: 2 bullish, 5 bearish.
  • HMTXF’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, HMTXF is a better buy in the short-term than FDMT.

Price Growth

FDMT (@Biotechnology) experienced а -13.48% price change this week, while HMTXF (@Biotechnology) price change was +6.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.11%. For the same industry, the average monthly price growth was -2.34%, and the average quarterly price growth was +0.25%.

Reported Earning Dates

FDMT is expected to report earnings on Mar 31, 2025.

Industries' Descriptions

@Biotechnology (-7.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FDMT($292M) has a higher market cap than HMTXF($9.34M). HMTXF YTD gains are higher at: -5.570 vs. FDMT (-68.806).
FDMTHMTXFFDMT / HMTXF
Capitalization292M9.34M3,128%
EBITDA-161.94MN/A-
Gain YTD-68.806-5.5701,235%
P/E RatioN/AN/A-
Revenue17KN/A-
Total Cash502MN/A-
Total Debt24.8MN/A-
FUNDAMENTALS RATINGS
HMTXF: Fundamental Ratings
HMTXF
OUTLOOK RATING
1..100
82
VALUATION
overvalued / fair valued / undervalued
1..100
3
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FDMTHMTXF
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
69%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
78%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
73%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
FDMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HMTXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ALMAX14.71N/A
N/A
Alger Weatherbie Specialized Growth A
OMSYX28.66-0.17
-0.59%
Invesco Main Street All Cap Y
IGRFX31.41-0.25
-0.79%
Delaware Ivy Mid Cap Growth R6
JHISX11.79-0.10
-0.84%
Janus Henderson VIT Global Sust Eq Ins
IVGAX22.19-0.23
-1.03%
VY® Invesco Growth and Income A

FDMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, FDMT has been loosely correlated with MPSYF. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if FDMT jumps, then MPSYF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FDMT
1D Price
Change %
FDMT100%
-2.47%
MPSYF - FDMT
42%
Loosely correlated
N/A
ANNX - FDMT
39%
Loosely correlated
-3.56%
QRON - FDMT
39%
Loosely correlated
+1.10%
ORMP - FDMT
38%
Loosely correlated
-1.67%
SCPH - FDMT
36%
Loosely correlated
+1.56%
More

HMTXF and

Correlation & Price change

A.I.dvisor tells us that HMTXF and DMAC have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HMTXF and DMAC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HMTXF
1D Price
Change %
HMTXF100%
-0.23%
DMAC - HMTXF
22%
Poorly correlated
-2.07%
BIVI - HMTXF
21%
Poorly correlated
-1.97%
AGEN - HMTXF
21%
Poorly correlated
+4.42%
DVHGF - HMTXF
21%
Poorly correlated
N/A
FDMT - HMTXF
12%
Poorly correlated
-2.47%
More